Effects of nal-IRI (MM-398) +/- 5-fluorouracil on quality of life (QoL) in NAPOLI-1: a phase 3 study in patients with metastatic pancreaticductal adenocarcinoma (mPDAC) previously treated with gemcitabine
Authors
Hubner, Richard ACubillo, A
Blanc, J
Melisi, D
Von Hoff, D
Wang-Gillam, A
Chen, L
Becker, C
Mamlouk, K
Belanger, B
Yang, Y
de Jong, F
Siveke, J
Affiliation
The Christie NHS Foundation Trust, ManchesterIssue Date
2016